Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer.

Bosnian journal of basic medical sciences - 29 Jul 2022

Ruan Mei, Sun Liyan, Qiu Wen, Dong Yanjie, Fang Chunmei, Cui Haiyan, Rong Jiansheng

Abstract excerpt

This study aimed to investigate the correlation between microRNA (miR)-4429 and epidermal growth factor receptor (EGFR), the expression and clinical significance of miR-4429 in patients with non-small cell lung cancer (NSCLC), and the relationship between miR-4429 and EGFR mutation in NSCLC patients. Blood samples were collected from 122 NSCLC patients and 72 healthy volunteers. miR-4429 expression and EGFR mRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to MicroRNAs

Share to Mutation

Share to Prognosis

Share to RNA, Messenger

Source

Open in PubMed Open full text

Identifiers

PMID: 35167433
DOI: 10.17305/bjbms.2021.6450
PMCID: PMC9392976

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer.PMID 35167433Read ↗

Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.Semantic proximity Read ↗

Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patientsSemantic proximity Read ↗

Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.Semantic proximity Read ↗

Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.Semantic proximity Read ↗

Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancerSemantic proximity Read ↗

Plasma miR ‐1247‐5p, miR ‐301b‐3p and miR ‐105‐5p as potential biomarkers for early diagnosis of non‐small cell lung cancerSemantic proximity Read ↗

Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.Semantic proximity Read ↗

MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung CancerSemantic proximity Read ↗

Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.Semantic proximity Read ↗

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancerSemantic proximity Read ↗

Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.Semantic proximity Read ↗

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.